drugset / Trial / NCT01774864

Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction

NCT01774864

Phase 3 Completed 349 enrolled Dong-A Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

Study Design : multi-center, double-blind, placebo-controlled, randomized, parallel group, fixed dose design Phase : Phase III

Timeline

Start
2011-04
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Udenafil Small molecule

Indications